Ethical implications of pharmacological enhancement of mood and cognition

Penn Bioethics Journal 1 (1):1-4 (2005)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 100,865

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

After Prozac.S. Matthew Liao & Rebecca Roache - 2011 - In Julian Savulescu, Ruud ter Meulen & Guy Kahane (eds.), Enhancing Human Capacities. Blackwell. pp. 245–256.
Health and Disease: Conceptual Perspectives and Ethical Implications.Dominic Sisti - 2009 - In Vardit Ravitsky, Autumn Fiester & Arthur L. Caplan (eds.), The Penn Center Guide to Bioethics. Springer Publishing Company. pp. 59.
Virtues-Based Policies for Pharmacological Cognitive Enhancement.Gavin Enck - 2020 - American Journal of Bioethics Neuroscience 11 (4):266-268.
F or over.Regulating Assisted - 2009 - In Vardit Ravitsky, Autumn Fiester & Arthur L. Caplan (eds.), The Penn Center Guide to Bioethics. Springer Publishing Company. pp. 295.
The Myth of Cognitive Enhancement Drugs.Hazem Zohny - 2015 - Neuroethics 8 (3):257-269.

Analytics

Added to PP
2013-10-29

Downloads
13 (#1,318,762)

6 months
13 (#253,952)

Historical graph of downloads
How can I increase my downloads?